from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2366c/-

LFCtreatmentdescriptionclass of inhibitor

-0.939

Amikacinug/mL Amikacintranslation

-1.145

Cap5-10ug/mL Capreomycintranslation

-0.929

Rox10-50 ug/mL Roxithromycintranslation

-0.412

SM2-5 ug/mL Streptomycintranslation

-0.984

Tet5-10 ug/mL Tetracyclinetranslation

1.051

Rif0.2-5ug/mL Rifampicintranscription

0.327

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.937

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.184

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.150

CPZ10-50 ug/mL Chlorpromazinerespiration

0.782

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.873

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.173

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.454

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.421

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.128

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.396

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.450

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.157

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.512

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.370

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.583

Nigericin50 uM Nigericinrespiration

0.808

TRC10-150 ug/mL Triclosanrespiration

-0.541

TRZ10-25 ug/mL Thioridazinerespiration

-0.657

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.839

menadione6-10 ug/mL Menadionerespiration

-0.146

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.591

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.022

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.567

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.488

NRP_1Non-replicating persistence stage 1dosRassociated

-0.012

Amp0.2mg/mL AmpicillincellWall

-0.371

Cephalexin20-100 ug/mL CephalexincellWall

-0.546

Cerulenin0.32-5 ug/mL CerulenincellWall

1.062

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.447

EMB10-20 ug/mL EthambutolcellWall

-0.876

Eta12-40 ug/mL EthionamidecellWall

-0.833

INH0.2-0.4 ug/mL IsoniazidcellWall

0.018

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.520

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.535

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.026

BZA0.12 mg/mL BenzamidearomaticAmides

0.292

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.479

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.719

H2O24 mM hydrogen peroxideDNAdamaging

-0.836

Levo10 ug/mL LevofloxacinDNAdamaging

0.068

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.307

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.260

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.625

UVUV-irradiationDNAdamaging

0.019

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.615

Antimycin12.5-50 ug/mL Antimycin A?

-0.751

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.280

PA_110-50 ug/mL Antitubercular compound PA-1?

0.084

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.319

PA8240.2-2 ug/mL PA-824?

2.203

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.636

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.375

Verapamil50 uM Verapamil?

-0.882

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.071

methoxatin10-20 ug/mL Methoxatin?